Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1994 2
1995 1
1996 3
1997 4
1998 7
1999 8
2000 8
2001 6
2002 15
2003 5
2004 16
2005 18
2006 16
2007 24
2008 16
2009 21
2010 16
2011 17
2012 30
2013 33
2014 17
2015 23
2016 20
2017 18
2018 25
2019 25
2020 28
2021 26
2022 17
2023 19
2024 21
2025 20
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

470 results

Results by year

Filters applied: . Clear all
Page 1
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Montoro MJ, Acha P, Haferlach C, Chan O, Navarro V, Kubota Y, Schulz F, Briski R, Al Ali NH, Xicoy B, Palomo L, López-Cadenas F, Bosch F, Meggendorfer M, González T, Eder LN, Jerez A, Wang Y, Campagna A, Betz B, Santini V, Bernal T, Such E, Platzbecker AS, Kewan T, Gurnari C, Zindel C, Kulasekararaj A, Voso MT, Sekeres M, Díaz-Varela N, Al-Kali A, Polini A, Diral E, Memoli M, Platzbecker U, Haase D, Zeidan AM, Díez-Campelo M, Garcia-Manero G, Wiseman DH, Della Porta MG, Germing U, Maciejewski J, Komrokji RS, Solé F, Haferlach T, Fenaux P, Valcárcel D. Montoro MJ, et al. Among authors: germing u. Leukemia. 2026 Apr 30. doi: 10.1038/s41375-026-02939-w. Online ahead of print. Leukemia. 2026. PMID: 42062555
Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.
Welsch J, Schulz F, Kasprzak A, Aul C, Götze KS, Nusch A, Lipke J, Parmentier S, Strupp C, Nachtkamp K, Kobbe G, Dietrich S, Gattermann N, Germing U. Welsch J, et al. Among authors: germing u. Ann Hematol. 2026 Apr 13;105(5):239. doi: 10.1007/s00277-026-06736-4. Ann Hematol. 2026. PMID: 41968189 Free PMC article.
High serum ferritin is associated with genetic instability in myelodysplastic neoplasms.
Ganster C, Treiber H, Westhofen G, Beier F, Rassaf T, Al-Ali HK, Stuhlmann R, Glass B, Bacher U, Shirneshan K, Brümmendorf TH, Germing U, Gattermann N, Haase D. Ganster C, et al. Among authors: germing u. J Cancer Res Clin Oncol. 2026 Apr 9;152(4):85. doi: 10.1007/s00432-026-06457-1. J Cancer Res Clin Oncol. 2026. PMID: 41957292 Free PMC article.
Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
Jäger P, Ralfs AA, Schulz F, Liebers N, Bobak J, Baermann BN, Twarock S, Hölscher A, Nachtkamp K, Kasprzak A, Lavikka J, Matkey F, Watrin T, Yaouti ME, Germing U, Dietrich S, Kobbe G. Jäger P, et al. Among authors: germing u. Ann Hematol. 2026 Apr 9;105(5):232. doi: 10.1007/s00277-026-06988-0. Ann Hematol. 2026. PMID: 41954734 Free PMC article.
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.
Zeidan AM, Santini V, Díez-Campelo M, Savona MR, Sekeres MA, Madanat YF, Fenaux P, Raza A, Mittelman M, Thépot S, Buckstein R, Germing U, Valcárcel D, Jonášová A, Shah S, Xia Q, Sun L, Navada S, Berry T, Platzbecker U, Komrokji RS. Zeidan AM, et al. Among authors: germing u. Blood Cancer J. 2026 Apr 7;16(1):55. doi: 10.1038/s41408-026-01501-2. Blood Cancer J. 2026. PMID: 41946674 Free PMC article. No abstract available.
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Lanino L, Hunter AM, Gagelmann N, Robin M, Dall'Olio D, Flamigni A, Sala C, Gurnari C, Wang YH, Pleyer L, Xicoy B, Montalban-Bravo G, Shih LY, Alsugair A, Fathima S, Gregorio C, Rollo C, Palomo L, Platzbecker AS, Asti G, Itzykson R, Sallman DA, Fariselli P, Kern W, Garcia-Manero G, Platzbecker U, Solé F, Diez-Campelo M, Maciejewski J, Bejar R, Thol F, Kroger N, Savona M, Fenaux P, Sanz G, Kordasti S, Santini V, Fontenay M, Zeidan AM, Komrokji RS, Haferlach T, Germing U, Castellani G, D'Amico S, Patnaik M, Ieva F, Solary E, Tefferi A, Padron E, Della Porta MG; iCPSS Alliance. Lanino L, et al. Among authors: germing u. J Clin Oncol. 2026 Mar 27:JCO2502116. doi: 10.1200/JCO-25-02116. Online ahead of print. J Clin Oncol. 2026. PMID: 41894646
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?
Selimoglu-Buet D, Chevret S, Santini V, Thépot S, Morabito M, Adès L, Laplane L, Giagounidis A, Droin N, Lübbert M, Sapena R, Nimubona S, Torregrosa-Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Paul F, Patriarca A, Stamatoullas A, Götze K, Chermat F, Platzbecker U, Fenaux P, Solary E, Itzykson R. Selimoglu-Buet D, et al. Among authors: germing u. Leukemia. 2026 Apr;40(4):806-815. doi: 10.1038/s41375-026-02901-w. Epub 2026 Mar 9. Leukemia. 2026. PMID: 41803403 Free PMC article. Clinical Trial.
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat.
Santini V, Zeidan AM, Van Eygen K, Fenaux P, Germing U, Madanat YF, Raza A, Savona MR, Sekeres MA, Thépot S, Raddi MG, Boyer T, Sun L, Wan Y, Berry T, Xia Q, Huang F, Dougherty S, Navada S, Feller F, Komrokji RS, Platzbecker U. Santini V, et al. Among authors: germing u. Leukemia. 2026 Feb;40(2):397-409. doi: 10.1038/s41375-025-02831-z. Epub 2026 Jan 12. Leukemia. 2026. PMID: 41526614 Free PMC article. Clinical Trial.
Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.
Meyer R, Rodriguez MJ, Caduc M, Kricheldorf K, Begemann M, Kraft F, Spier I, Dey D, Güzel N, Becker K, Baumeister J, S de Toledo MA, Isfort S, Germing U, Aretz S, Brümmendorf TH, Kurth I, Elbracht M, Teichmann LL, Koschmieder S. Meyer R, et al. Among authors: germing u. Blood Cancer J. 2026 Jan 5;16(1):2. doi: 10.1038/s41408-025-01433-3. Blood Cancer J. 2026. PMID: 41491914 Free PMC article. No abstract available.
A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
Döhner H, Späth D, Saadati M, Fiedler W, Götze K, Koller E, Westermann J, Vogel W, Heuser M, Lübbert M, Tischler HJ, Germing U, Teichmann LL, Fransecky L, Wölfler A, Nachbaur D, Hertenstein B, Schroers R, Martens U, von Harsdorf S, Radsak M, Aschauer G, Weißhaar S, Corbacioglu A, Schrade A, Gaidzik VI, Thol F, Paschka P, Bullinger L, Benner A, Döhner K, Ganser A. Döhner H, et al. Among authors: germing u. Blood. 2026 Apr 9;147(15):1735-1748. doi: 10.1182/blood.2025030722. Blood. 2026. PMID: 41490515 Free PMC article. Clinical Trial.
470 results